Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 2Multiple Myeloma 2Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Mesothelioma, Malignant 1Melanoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 104fludarabine 61Methotrexate 50Dexamethasone 47Cytarabine 46fludarabine phosphate 45Vincristine 43blinatumomab 36Whole-Body Irradiation 33Mycophenolic Acid 30Tacrolimus 26Melphalan 26Mercaptopurine 25venetoclax 24Specimen Handling 24Etoposide 24pegaspargase 21Peripheral Blood Stem Cell Transplantation 21Stem Cell Transplantation 20Granulocyte Colony-Stimulating Factor 19Doxorubicin 19Calcium Dobesilate 19Busulfan 19Rituximab 16Prednisone 16Filgrastim 16Daunorubicin 16Asparaginase 16merphos 15Thiotepa 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × In Situ Hybridization, Fluorescence × 1 year × Clear all
NCT07403630 2026-02-17

IT-TCP POS

Azienda Ospedaliero-Universitaria di Parma

Phase NA Recruiting
300 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Squamous Cell, Melanoma, Multiple Myeloma, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡